Literature DB >> 7957405

Uncooked cornstarch treatment for hepatic phosphorylase kinase deficiency.

A Nakai1, Y Shigematsu, T Takano, Y Kikawa, M Sudo.   

Abstract

UNLABELLED: A 5-year-old boy with short stature, hepatomegaly and motor weakness due to hepatic phosphorylase kinase deficiency is described. Laboratory data showed mild hypoglycaemia and metabolic acidosis, hepatic dysfunction, and a low insulin-like growth factor-I level. Mild hypoglycaemia, marked ketosis and insufficient growth hormone secretion were revealed at night. Serum total and free carnitine levels were low and the acyl/total carnitine ratio was high. Urinary acylcarnitine profile using fast atom bombardment and tandem mass spectrometry showed increased excretion of acetylcarnitine and dicarboxylylcarnitines. These endocrinological and metabolic abnormalities and clinical symptoms were improved with uncooked cornstarch treatment.
CONCLUSION: Uncooked cornstarch treatment may be helpful in hepatic phosphorylase deficiency.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7957405     DOI: 10.1007/BF02190663

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  8 in total

1.  The natural history of liver glycogenosis due to phosphorylase kinase deficiency: a longitudinal study of 41 patients.

Authors:  P J Willems; W J Gerver; R Berger; J Fernandes
Journal:  Eur J Pediatr       Date:  1990-01       Impact factor: 3.183

2.  Prenatal diagnosis of isovaleric acidemia by fast atom bombardment and tandem mass spectrometry.

Authors:  Y Shigematsu; Y Kikawa; M Sudo; H Kanaoka; M Fujioka; M Dan
Journal:  Clin Chim Acta       Date:  1991-12-16       Impact factor: 3.786

Review 3.  Glycogen storage disease: recommendations for treatment.

Authors:  J Fernandes; J V Leonard; S W Moses; M Odièvre; M di Rocco; J Schaub; G P Smit; K Ullrich; P Durand
Journal:  Eur J Pediatr       Date:  1988-04       Impact factor: 3.183

4.  Growth and endocrine changes in the hepatic glycogenoses.

Authors:  D B Dunger; A T Holder; J V Leonard; J Okae; M A Preece
Journal:  Eur J Pediatr       Date:  1982-05       Impact factor: 3.183

Review 5.  Carnitine deficiency syndromes.

Authors:  G N Breningstall
Journal:  Pediatr Neurol       Date:  1990 Mar-Apr       Impact factor: 3.372

6.  Myopathy and growth failure in debrancher enzyme deficiency: improvement with high-protein nocturnal enteral therapy.

Authors:  A E Slonim; R A Coleman; W S Moses
Journal:  J Pediatr       Date:  1984-12       Impact factor: 4.406

7.  Difficult hGH treatment in a patient with type III glycogen storage disease.

Authors:  D Larizza; G Maggiore; D Marzani; M Maghnie; R Ciceri
Journal:  Eur J Pediatr       Date:  1986-04       Impact factor: 3.183

Review 8.  Growth hormone therapy in short children without classical growth hormone deficiency.

Authors:  J R Bierich
Journal:  J Endocrinol Invest       Date:  1989       Impact factor: 4.256

  8 in total
  3 in total

1.  Variability of disease spectrum in children with liver phosphorylase kinase deficiency caused by mutations in the PHKG2 gene.

Authors:  Deeksha S Bali; Jennifer L Goldstein; Keri Fredrickson; Catherine Rehder; Anne Boney; Stephanie Austin; David A Weinstein; Richard Lutz; Avihu Boneh; Priya S Kishnani
Journal:  Mol Genet Metab       Date:  2013-12-19       Impact factor: 4.797

2.  Characteristic growth pattern in male X-linked phosphorylase-b kinase deficiency (GSD IX).

Authors:  H M Schippers; G P A Smit; J P Rake; G Visser
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

Review 3.  Features of chinese patients with sitosterolemia.

Authors:  Zhizi Zhou; Xueying Su; Yanna Cai; Tzer Hwu Ting; Wen Zhang; Yunting Lin; Aijing Xu; Xiaojian Mao; Chunhua Zeng; Li Liu; Xiuzhen Li
Journal:  Lipids Health Dis       Date:  2022-01-18       Impact factor: 3.876

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.